Barclays’s Filana Therapeutics, Inc. Common Stock FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $96K | Buy |
|
|||||
|
2025
Q3 | $265 | Sell |
|
|||||
|
2025
Q2 | $4.95K | Sell |
|
|||||
|
2025
Q1 | $66K | Sell |
|
|||||
|
2024
Q4 | $221K | Buy |
|
|||||
|
2024
Q3 | $2.2M | Buy |
|
|||||
|
2024
Q2 | $264K | Sell |
|
|||||
|
2024
Q1 | $1.04M | Sell |
|
|||||
|
2023
Q4 | $2.38M | Buy |
|
|||||
|
2023
Q3 | $445K | Buy |
|
|||||
|
2023
Q2 | $489K | Sell |
|
|||||
|
2023
Q1 | $783K | Sell |
|
|||||
|
2022
Q4 | $1.29M | Buy |
|
|||||
|
2022
Q3 | $901K | Buy |
|
|||||
|
2022
Q2 | $581K | Sell |
|
|||||
|
2022
Q1 | $901K | Sell |
|
|||||
|
2021
Q4 | $4.85M | Buy |
|
|||||
|
2021
Q3 | $3.52M | Buy |
|
|||||
|
2021
Q2 | $414K | Sell |
|
|||||
|
2021
Q1 | $1.23M | Buy |
|
|||||
|
2020
Q4 | $72K | Sell |
|
|||||
|
2020
Q3 | $122K | Sell |
|
|||||
|
2020
Q2 | $91K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $2K | Sell |
|
|||||
|
2013
Q2 | $120K | Buy |
|